MedTrace Logo

Comparative Effects of High Intensity and Eccentric Resistance Among School Going Basketball Players

NCT07329439 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2026-01-09

No results posted yet for this study

Summary

This will be experimental randomized clinical trial conducted in Pakistan sports board, Sacred Heart cathedral high school . Female school going basketball players will be screened for eligibility according to inclusion and exclusion criteria. Informed consent will be obtained from eligible participants. All participants will go through randomization by Online Randomization tool. Information regarding number of groups, number of participants in each group and total number of participants will be entered. This will be a single blinded study in which outcome assessor will be blinded to ensure accuracy and reduce biasness. Sample size according to G power will be 40.

Conditions

  • Basketball

Interventions

OTHER

High intensity resistance training

group A receive high intensity resistance training, 8-week duration for significant results. Exercises will be performed at starting 50% of one-repetition maximum (1RM) for hypertrophy and strength gains

OTHER

Eccentric resistance training

Group B receive eccentric resistance training, 8-week duration for significant results, exercise training three times a week.

Sponsors & Collaborators

  • Riphah International University

    lead OTHER

Principal Investigators

  • Masooma Irfan, DPT · Riphah International University

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
13 Years
Max Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-11-21
Primary Completion
2025-10-05
Completion
2025-11-05

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07329439 on ClinicalTrials.gov